Assessing the environmental impact of medicines in Italy using data from the Italian Medicines Agency
British Journal of Clinical Pharmacology · 2025
DOI: 10.1002/bcp.70046 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2025. Verfasst von Valentina Giunchi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Environmental Exposure. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aim
This study builds on the environmental risk analysis presented in the 2022 National Report on Medicines Use in Italy by the Italian Medicines Agency and aims to assess the environmental risk posed by medicines in Italy and its regions.
Methods
The analysis selected 90 medicines based on three criteria: high utilization, low predicted no effect concentration (PNEC), and inclusion or candidacy for the European Watch List. For each medicine, the environmental risk was computed as the ratio between the predicted environmental concentration (PEC) and the PNEC. The PEC was derived following the approach of the Swedish Association of Pharmaceutical Industries and Italian drug utilization data. The risk was classified high if the ratio was greater than 10 and moderate if greater than 1.
Results
Overall, 13 medicines were identified as posing a high risk, including cardiovascular agents, antibiotics, analgesics, antidepressants and antiparasitic agents. The high risk was driven by either a very low PNEC (eg, estradiol and lacidipine) or high utilization (eg, amoxicillin, ibuprofen and diclofenac). Regional analysis showed higher risk due to high consumption for azithromycin and ofloxacin in central and southern Italy, and for levonorgestrel in northern Italy.
Conclusion
This study points to the need for prioritizing targeted sampling in surface waters for medicines estimated at high risk. To prevent and mitigate the risk, a more conscious clinical practice coupled with appropriate waste management are required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
- Italian Medicines Agency (AIFA), Rome, Italy.
ORCID-Profile: Valentina Giunchi, Michele Fusaroli, Agnese Cangini, Filomena Fortinguerra, Carlotta Lunghi
Zitieren
APA
Giunchi, V., Fusaroli, M., Cangini, A., Fortinguerra, F., Zito, S., Pierantozzi, A., Lunghi, C., Poluzzi, E., & Trotta, F. (2025). Assessing the environmental impact of medicines in Italy using data from the Italian Medicines Agency. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70046
Vancouver
Giunchi V, Fusaroli M, Cangini A, Fortinguerra F, Zito S, Pierantozzi A, et al. Assessing the environmental impact of medicines in Italy using data from the Italian Medicines Agency. British Journal of Clinical Pharmacology. 2025. doi:10.1002/bcp.70046
BibTeX
@article{Giunchi2025,
author = {Giunchi, Valentina and Fusaroli, Michele and Cangini, Agnese and Fortinguerra, Filomena and Zito, Simona and Pierantozzi, Andrea and Lunghi, Carlotta and Poluzzi, Elisabetta and Trotta, Francesco},
title = {Assessing the environmental impact of medicines in Italy using data from the Italian Medicines Agency},
journal = {British Journal of Clinical Pharmacology},
year = {2025},
doi = {10.1002/bcp.70046}
}
EUVIMED